Physician profile
Nirali Shah
NPI 1295397008
$14,910.33
in general payments reported to CMS, 2019-2025
23 companies · $2,578 in 2025
The $2,578 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $1,067 · 2021: $2,811 · 2022: $6,125 · 2023: $541 · 2024: $1,446 · 2025: $2,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,369 · Food and Beverage: $2,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,368.58 |
| Food and Beverage | $2,196.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $3,385.08 | 2022-2024 | |
| Treace Medical Concepts, INC. | $3,078.74 | 2022-2025 | |
| Arthrex, INC. | $1,952.98 | 2022-2024 | |
| Smith+Nephew, INC. | $1,441.82 | 2019-2025 | Grafix Pl, Pico 7 |
| Mid-Atlantic Surgical Systems, LLC | $1,253.52 | 2020-2021 | |
| Medical Device Business Services, INC. | $1,003.89 | 2020-2022 | |
| Medline Industries Lp | $934.68 | 2025 | |
| Organogenesis INC. | $399.48 | 2020-2022 | |
| Nevro Corp. | $318.94 | 2022-2024 | Senza |
| Misonix INC | $268.89 | 2021 | |
| Voom Medical Devices, INC. | $142.57 | 2025 | Revcon |
| Averitas Pharma INC. | $121.80 | 2023 | Qutenza |
| Axogen | $120.48 | 2019-2023 | Avance Nerve Graft |
| Acell, INC. | $98.34 | 2019 | |
| Zimmer Biomet Holdings, INC. | $90.15 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $74.88 | 2021 | |
| Stryker Corporation | $57.71 | 2022-2025 | Viaflow |
| Abbvie INC. | $46.35 | 2021 | |
| Amgen INC. | $39.26 | 2024-2025 | Krystexxa |
| Bioventus LLC | $25.62 | 2025 | Exogen Ultrasound Bone Healing System |
| Merck Sharp & Dohme LLC | $20.60 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.27 | 2025 | Nuzyra |
| Kerecis Limited | $15.28 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirali Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.